-
The spreading chain of the epidemic continues to extend. What is the future trend?
Time of Update: 2021-08-04
Still within the scope of protection, it is not necessary for the general population to be vaccinated temporarily This round of the local epidemic has puzzled many people: "Why are they still infected after the vaccine?" Shao Yiming, a member of the expert group on vaccine research and development of the State Council’s Joint Prevention and Control Mechanism Scientific Research Group, explained: “After being infected after a vaccine, we call it a'breakthrough case'.
-
Improve and implement the review and evaluation system to promote the high-quality development of public hospitals
Time of Update: 2021-08-04
In order to further improve the review and evaluation system of hospitals in China, guide hospitals to strengthen their own construction and management, promote the high-quality development of hospitals in China, and better meet the needs of the people for medical services, recently, it was sponsored by the Institute of Hospital Management of the National Health Commission and Nanchang University The “Sixth China Hospital Evaluation and High-quality Development Conference” hosted by the First Affiliated Hospital was held in Nanchang .
-
my country's artificial intelligence diagnosis system for malaria parasites is officially launched
Time of Update: 2021-08-04
Academy of Sciences After an exclusive visit to a laboratory of the Military Medical Research Institute by CCTV reporter Su Zhou of the Central Station, he saw that the research personnel of the Military Medical Research Institute can quickly and easily identify the collected malaria parasites through the latest artificial intelligence diagnosis system developed during their assistance in Africa.
-
Delta strain accelerates the spread of global anti-epidemic challenges
Time of Update: 2021-08-04
The global anti-epidemic challenges are severe The delta strain of the new crown mutant virus is spreading rapidly around the world, and the epidemic in many countries and regions has returned or even reappeared at the peak of the epidemic.
-
The National Natural Science Foundation of China announces the list of professional review teams in the field of medical science
Time of Update: 2021-08-04
Announcement on the announcement of the list of professional review teams in the field of medical science in 2021 Announcement on the announcement of the list of the professional re
-
[Overview] Yangtze River's 2 billion injections make another city and Pfizer loses half of the country
Time of Update: 2021-08-04
Wonderful contentWonderful contentA few days ago, the official website of the State Food and Drug Administration showed that the supplementary application of Parecoxib Sodium for injection from Guangzhou Hairui Pharmaceuticals of Yangtze River Pharmaceutical Group was approved.
-
Approved!
Time of Update: 2021-08-04
Wonderful contentWonderful contentA few days ago, the official website of the State Food and Drug Administration showed that Borui Pharmaceuticals (Suzhou) was approved for imitation of oseltamivir phosphate capsules for production in Category 4, which is deemed to have been reviewed .
-
Popular Science: What's the "Breakthrough Infection" of the New Coronavirus
Time of Update: 2021-08-04
Zhang Jun said that in research reports with strong data science, the effectiveness of various vaccines to prevent death and severe illness is significantly higher than that of preventing mild illness or infection, but there are still severe illnesses and deaths caused by "breakthrough infection".
-
The National Medical Reform Conference was held, revealing 4 key tasks!
Time of Update: 2021-08-04
Medical Network News, August 2 Recently, the 2021 National Medical Reform Work Video and Telephone Conference was held . The Standing Committee of the Political Bureau of the CPC Central Committee
-
Drugs that face an important review decision by the US FDA in August 2021!
Time of Update: 2021-08-04
Entering August, a number of drugs will usher in an important review decision by the FDA .
Reference source: Biotech Stocks Facing FDA Decision In August 2021
-
The third one!
Time of Update: 2021-08-03
The target ADC drug SYSA1801 of CSPC has been clinically approved in the United States and China, and it is planned to be developed for the treatment of advanced pancreatic cancer with positive expression of Claudin 18.
-
China's generic drug development has changed dramatically in the past 6 years
Time of Update: 2021-08-03
Source: PharmaGoConsistency evaluation gradually withdrewConsistency evaluation gradually withdrewAt the end of 2018, the "Announcement on Matters Concerning the Quality and Efficacy Consistency Evaluation of Generic Drugs" issued by the National Medical Products Administration pointed out that the varieties that passed the quality and efficacy consistency evaluation of generic drugs were given priority to be included in the catalog.
-
Hengrui will win over 1.5 billion anesthetics
Time of Update: 2021-08-03
According to data, the propofol medium/long-chain fat emulsion injection was developed by Fresenius Kabi, and has been approved for marketing in more than 10 countries including Germany, Austria, and Japan.
-
Shanghai Pharmaceuticals Pregabalin Capsules Received U.S. FDA Approval Number
Time of Update: 2021-08-03
Pregabalin capsules original research plant for Pfizer, overseas production and sales of manufacturers are Actavis, Teva, Dr.
According to the Evaluate Pharma database, global sales of the drug will be approximately US$2.
089 billion in 2020, and US sales of approximately US$355 million .
-
Suppress inflammation and fibrosis FDA approves the first ROCK2 inhibitor
Time of Update: 2021-08-03
Recently, Kadmon announced that the US FDA approved the company's Rezurock (belumosudil) for the treatment of chronic graft-versus-host disease (cGVHD) patients over 12 years of age who have received two pre-systemic treatments .
-
Hengrui Medicine: Subsidiary received two drug clinical trial approval notices
Time of Update: 2021-08-03
has recently received the approval of the State Food and Drug Administration to issue the "Drug Clinical Trial Approval Notice" on remazolam tosylate for injection and HRS3797 for injection.
-
AbbVie's application for new indications for oral JAK1 inhibitor Rinvoq is delayed in U.S. review
Time of Update: 2021-08-03
The sNDA seeks to approve a new indication for Rinvoq: for the treatment of adult patients with moderate to severe atopic dermatitis (AD) .
-
837 provinces released three batches of medical insurance drug lists!
Time of Update: 2021-08-03
3. Take care of medication habitsThe annual digestion list is determined according to the time sequence of the drugs entering the provincial drug catalog, with the last in first back, the first in back, and the basic drugs back in .
-
Xinjiang began to link the fifth batch of national procurement results
Time of Update: 2021-08-03
Taking budesonide suspension for inhalation as an example, Meinenet data shows that in 2020, the top 1 terminal inhalation products of public medical institutions in China will have sales of more than 5 billion yuan, and the original research drug company AstraZeneca has a market share of 94.
-
What is the difference between the two injections of the new crown vaccine and the "mixed" antibody protection?
Time of Update: 2021-08-03
This study from Umeå University in Sweden, named CoVacc, showed that after a shot of ChAdOx1n CoV-19 new crown vaccine, a second shot of mRNA-1273 induced higher antibody titers and neutralizing antibody titers , The protection against mutant strains in in vitro experiments is also stronger .
